Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnstein Norheim

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 2026
Gunnstein Norheim, Marte Petrikke Grenersen
Clinical Trials (London, England)|March 3, 2021
Mapping time use in clinical trials for vaccines against emerging infectious diseasesHenshaw Mandi, Solomon Abebe Yimer, Gunnstein Norheim
Human Vaccines & Immunotherapeutics|August 23, 2016
Ebola vaccines - Where are we?Sara Viksmoen Watle, Gunnstein Norheim, John-Arne Røttingen
BMJ Global Health|August 21, 2020
Rift valley fever: diagnostic challenges and investment needs for vaccine developmentVelislava Petrova, Paul Kristiansen, Gunnstein Norheim, et al.
Vaccine|April 30, 2013
Emergence of serogroup X meningococcal disease in Africa: need for a vaccineOuli Xie, Andrew J Pollard, Judith E Mueller, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 4, 2026
Joakim Øverbø, Eli Heen, Gunnstein Norheim, et al.
Journal of Clinical Microbiology|October 7, 2005
Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexesPierre Nicolas, Gunnstein Norheim, Eric Garnotel, et al.
BMJ Global Health|March 23, 2019
Diagnostic applications for Lassa fever in limited-resource settingsDevy M Emperador, Solomon A Yimer, Laura T Mazzola, et al.
Vaccine|May 20, 2004
Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A diseaseGunnstein Norheim, E Arne Høiby, Dominique A Caugant, et al.
Journal of Proteome Research|September 19, 2017
N<sub>ε</sub>- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are AcetylatedAlemayehu Godana Birhanu, Solomon Abebe Yimer, Carol Holm-Hansen, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 2026
Gunnstein Norheim, Marte Petrikke Grenersen
Clinical Trials (London, England)|March 3, 2021
Mapping time use in clinical trials for vaccines against emerging infectious diseasesHenshaw Mandi, Solomon Abebe Yimer, Gunnstein Norheim
Human Vaccines & Immunotherapeutics|August 23, 2016
Ebola vaccines - Where are we?Sara Viksmoen Watle, Gunnstein Norheim, John-Arne Røttingen
BMJ Global Health|August 21, 2020
Rift valley fever: diagnostic challenges and investment needs for vaccine developmentVelislava Petrova, Paul Kristiansen, Gunnstein Norheim, et al.
Vaccine|April 30, 2013
Emergence of serogroup X meningococcal disease in Africa: need for a vaccineOuli Xie, Andrew J Pollard, Judith E Mueller, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 4, 2026
Joakim Øverbø, Eli Heen, Gunnstein Norheim, et al.
Journal of Clinical Microbiology|October 7, 2005
Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexesPierre Nicolas, Gunnstein Norheim, Eric Garnotel, et al.
BMJ Global Health|March 23, 2019
Diagnostic applications for Lassa fever in limited-resource settingsDevy M Emperador, Solomon A Yimer, Laura T Mazzola, et al.
Vaccine|May 20, 2004
Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A diseaseGunnstein Norheim, E Arne Høiby, Dominique A Caugant, et al.
Journal of Proteome Research|September 19, 2017
N<sub>ε</sub>- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are AcetylatedAlemayehu Godana Birhanu, Solomon Abebe Yimer, Carol Holm-Hansen, et al.
Pageof 5